Dose-Response Relationships and Pharmacodynamic Parameters for Nondepolarizing Neuromuscular Blocking Drugs in Human Subjects
| ED50 (mg/kg) | ED95 (mg/kg) | CE50 (ng/mL) | Ke0 (min-1) | Intubating Dose (mg/kg) | Maximum Block (%) | Time to Maximum Block (min) | Clinical Duration of Response (min) | Long-acting | d-Tubocurarine | 0.23 | 0.48 | 370 | 0.13 | 0.6 | 97 | 5.7 | 81 | Pancuronium | 0.036 | 0.067 | 88 | | 0.08 | 100 | 2.9 | 86 | Intermediate-acting | Rocuronium | 0.147 | 0.305 | 3510 | 0.405 | 0.6 | 100 | 1.7 | 36 | Vecuronium | 0.027 | 0.043 | 92 | 0.17 | 0.1 | 100 | 2.4 | 44 | Atracurium | 0.12 | 0.21 | 449 | 0.13 | 0.5 | 100 | 3.2 | 46 | Cisatracurium | 0.026 | 0.04 | 126-158 | 0.07-0.09 | 0.1 | 100 | 5.2 | 45 | Short-acting | Mivacurium | 0.039 | 0.067 | 79.9 | 0.18 | 0.15 | 100 | 3.3 | 16.8 |
|
a Derived using simultaneous pharmacokinetic/pharmacodynamic modeling.
b Time from injection of the intubating dose to recovery of twitch to 25% of control.